Loading...

Orgenesis Inc.

ORGSNASDAQ
Healthcare
Biotechnology
$1.00
$0.98(4445.45%)

Orgenesis Inc. (ORGS) Company Profile & Overview

Explore Orgenesis Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Orgenesis Inc. (ORGS) Company Profile & Overview

Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.

SectorHealthcare
IndustryBiotechnology
CEOVered Caplan

Contact Information

480 659 6404
20271 Goldenrod Lane, Germantown, MD, 20876

Company Facts

146 Employees
IPO DateMar 13, 2012
CountryUS
Actively Trading

Frequently Asked Questions

;